{"id":"https://openalex.org/W2400828834","doi":"https://doi.org/10.1111/acer.13093","title":"Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development","display_name":"Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development","alternate_titles":[],"publication_year":2016,"publication_date":"2016-05-17","ids":{"openalex":"https://openalex.org/W2400828834","doi":"https://doi.org/10.1111/acer.13093","mag":"2400828834","pmid":"https://pubmed.ncbi.nlm.nih.gov/27184259","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4930402"},"language":"en","primary_location":{"id":"doi:10.1111/acer.13093","doi":"https://doi.org/10.1111/acer.13093","is_oa":false,"landing_page_url":"https://doi.org/10.1111/acer.13093","pdf_url":null,"source":{"id":"https://openalex.org/S115510430","display_name":"Alcoholism Clinical and Experimental Research","issn_l":"0145-6008","issn":["0145-6008","1530-0277","2993-7175"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alcoholism: Clinical and Experimental Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2400828834"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4930402/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054654890","display_name":"Raye Z. Litten","orcid":"https://orcid.org/0000-0001-7497-0809","observed_orcids":["https://orcid.org/0000-0001-7497-0809","https://orcid.org/0000-0002-5273-2989"]},"institutions":[{"id":"https://openalex.org/I4210121815","display_name":"National Institute on Alcohol Abuse and Alcoholism","ror":"https://ror.org/02jzrsm59","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210121815"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Raye Z. Litten","raw_affiliation_strings":["NIAAA's Clinical Investigations Group (NCIG), Division of Medications Development, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIAAA's Clinical Investigations Group (NCIG), Division of Medications Development, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210121815"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014344861","display_name":"Daniel E. Falk","orcid":"https://orcid.org/0000-0002-3753-2786","observed_orcids":["https://orcid.org/0000-0002-3753-2786"]},"institutions":[{"id":"https://openalex.org/I4210121815","display_name":"National Institute on Alcohol Abuse and Alcoholism","ror":"https://ror.org/02jzrsm59","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210121815"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel E. Falk","raw_affiliation_strings":["NIAAA's Clinical Investigations Group (NCIG), Division of Medications Development, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIAAA's Clinical Investigations Group (NCIG), Division of Medications Development, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210121815"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103825432","display_name":"Megan L. Ryan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121815","display_name":"National Institute on Alcohol Abuse and Alcoholism","ror":"https://ror.org/02jzrsm59","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210121815"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Megan L. Ryan","raw_affiliation_strings":["NIAAA's Clinical Investigations Group (NCIG), Division of Medications Development, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIAAA's Clinical Investigations Group (NCIG), Division of Medications Development, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210121815"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001823672","display_name":"Joanne B. Fertig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121815","display_name":"National Institute on Alcohol Abuse and Alcoholism","ror":"https://ror.org/02jzrsm59","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210121815"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joanne B. Fertig","raw_affiliation_strings":["NIAAA's Clinical Investigations Group (NCIG), Division of Medications Development, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIAAA's Clinical Investigations Group (NCIG), Division of Medications Development, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210121815"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5054654890"],"corresponding_institution_ids":["https://openalex.org/I4210121815"],"apc_list":{"value":4110,"currency":"USD","value_usd":4110},"apc_paid":null,"fwci":1.0289,"has_fulltext":false,"cited_by_count":76,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.69612508,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"40","issue":"7","first_page":"1368","last_page":"1379"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11207","display_name":"Alcohol Consumption and Health Effects","score":0.007699999958276749,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alcoholism","display_name":"alcoholism","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7879999876022339},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9520000219345093},{"id":"https://openalex.org/keywords/acamprosate","display_name":"acamprosate","score":0.9810000061988831},{"id":"https://openalex.org/keywords/druggable-targets","display_name":"druggable targets","score":0.8709999918937683},{"id":"https://openalex.org/keywords/screening-model","display_name":"screening model","score":0.7919999957084656},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.7900000214576721},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.6029999852180481},{"id":"https://openalex.org/keywords/drug-adoption","display_name":"drug adoption","score":0.5590000152587891},{"id":"https://openalex.org/keywords/valley-of-death","display_name":"valley of death","score":0.75},{"id":"https://openalex.org/keywords/stakeholder-collaboration","display_name":"stakeholder collaboration","score":0.703000009059906},{"id":"https://openalex.org/keywords/national-institute-on-alcohol-abuse-and-alcoholism","display_name":"National Institute on Alcohol Abuse and Alcoholism","score":0.8510000109672546}],"concepts":[{"id":"https://openalex.org/C10679952","wikidata":"https://www.wikidata.org/wiki/Q5308937","display_name":"Druggability","level":3,"score":0.687628984451294},{"id":"https://openalex.org/C2779992327","wikidata":"https://www.wikidata.org/wiki/Q337668","display_name":"Acamprosate","level":5,"score":0.6602638959884644},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5627163052558899},{"id":"https://openalex.org/C2779442783","wikidata":"https://www.wikidata.org/wiki/Q15326","display_name":"Alcohol use disorder","level":3,"score":0.5189680457115173},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.43995341658592224},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.3345605731010437},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.32280591130256653},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2496871054172516},{"id":"https://openalex.org/C2781066024","wikidata":"https://www.wikidata.org/wiki/Q156","display_name":"Alcohol","level":2,"score":0.09966668486595154},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D006040","descriptor_name":"Goals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019973","descriptor_name":"Alcohol-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/acer.13093","doi":"https://doi.org/10.1111/acer.13093","is_oa":false,"landing_page_url":"https://doi.org/10.1111/acer.13093","pdf_url":null,"source":{"id":"https://openalex.org/S115510430","display_name":"Alcoholism Clinical and Experimental Research","issn_l":"0145-6008","issn":["0145-6008","1530-0277","2993-7175"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alcoholism: Clinical and Experimental Research","raw_type":"journal-article"},{"id":"pmid:27184259","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27184259","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alcoholism, clinical and experimental research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4930402","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4930402/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Alcohol Clin Exp Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4930402","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4930402/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Alcohol Clin Exp Res","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1997962874","display_name":null,"funder_award_id":"Z99\u2010AA999999","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332162","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":66,"referenced_works":["https://openalex.org/W1486909174","https://openalex.org/W1510797412","https://openalex.org/W1570093058","https://openalex.org/W1761714741","https://openalex.org/W1829470622","https://openalex.org/W1839921965","https://openalex.org/W1871434514","https://openalex.org/W1909356815","https://openalex.org/W1922973259","https://openalex.org/W1932563541","https://openalex.org/W1942488336","https://openalex.org/W1950055679","https://openalex.org/W1970051522","https://openalex.org/W1974267840","https://openalex.org/W1975116467","https://openalex.org/W1977068881","https://openalex.org/W1980612883","https://openalex.org/W1991882455","https://openalex.org/W1995302510","https://openalex.org/W1998239347","https://openalex.org/W2006801926","https://openalex.org/W2006833508","https://openalex.org/W2025769282","https://openalex.org/W2028133614","https://openalex.org/W2033247361","https://openalex.org/W2037992542","https://openalex.org/W2039953940","https://openalex.org/W2050338746","https://openalex.org/W2051036306","https://openalex.org/W2055949337","https://openalex.org/W2060427373","https://openalex.org/W2063757665","https://openalex.org/W2071549014","https://openalex.org/W2074406420","https://openalex.org/W2074613132","https://openalex.org/W2080846140","https://openalex.org/W2086175717","https://openalex.org/W2086197871","https://openalex.org/W2092414617","https://openalex.org/W2096009052","https://openalex.org/W2104284600","https://openalex.org/W2106405930","https://openalex.org/W2107026089","https://openalex.org/W2107687266","https://openalex.org/W2110504918","https://openalex.org/W2113673166","https://openalex.org/W2118475046","https://openalex.org/W2119106378","https://openalex.org/W2121408324","https://openalex.org/W2122807925","https://openalex.org/W2123224317","https://openalex.org/W2126709720","https://openalex.org/W2142512846","https://openalex.org/W2143344901","https://openalex.org/W2149660440","https://openalex.org/W2150537657","https://openalex.org/W2166550586","https://openalex.org/W2169220235","https://openalex.org/W2170296677","https://openalex.org/W2170409651","https://openalex.org/W2203515938","https://openalex.org/W2207035985","https://openalex.org/W2318393448","https://openalex.org/W2417560069","https://openalex.org/W2525236030","https://openalex.org/W2994292727"],"related_works":["https://openalex.org/W1999116765","https://openalex.org/W2782063084","https://openalex.org/W2122807925","https://openalex.org/W2289934799","https://openalex.org/W2810340561","https://openalex.org/W4387917608","https://openalex.org/W4415138699","https://openalex.org/W2986662798","https://openalex.org/W2346450530","https://openalex.org/W2028133614"],"abstract_inverted_index":{"For":[0],"more":[1,37,88],"than":[2,90],"25":[3],"years,":[4],"advances":[5],"have":[6],"been":[7],"made":[8],"in":[9,43,81,158,240,259],"developing":[10,263],"medications":[11,85,139,215,250,264],"to":[12,40,72,79,149,183,245],"treat":[13],"alcohol":[14,256],"use":[15,228],"disorder":[16,104],"(AUD),":[17],"highlighted":[18],"by":[19],"the":[20,63,82,126,131,173,194,255],"U.S.":[21],"Food":[22],"and":[23,30,32,69,94,111,125,128,185,220,224,232,262],"Drug":[24],"Administration's":[25],"approval":[26],"of":[27,84,117,130,168,175,188,209,229],"naltrexone":[28],"(oral":[29],"long-acting)":[31],"acamprosate.":[33],"Despite":[34],"this":[35,44,171,242],"progress,":[36],"work":[38,56],"remains":[39],"be":[41],"done":[42],"area":[45],"because":[46],"these":[47],"medications,":[48],"although":[49],"effective":[50,89],"for":[51,57,62,102,146,193,205,213,265],"some":[52],"people,":[53],"do":[54],"not":[55,156],"everyone.":[58],"A":[59,137],"high":[60],"priority":[61],"National":[64],"Institute":[65],"on":[66,249],"Alcohol":[67,70],"Abuse":[68],"is":[71,109,155,244],"put":[73],"into":[74,134],"place":[75],"a":[76,103,152,162,247],"solid":[77],"infrastructure":[78],"aid":[80,254],"development":[83,140,177,251],"that":[86,151,252],"are":[87,178,191,203,211],"those":[91],"currently":[92],"available":[93],"with":[95],"few":[96],"side":[97],"effects.":[98],"Medication":[99],"development,":[100],"especially":[101],"as":[105,107,165,180],"complex":[106],"AUD,":[108,184],"challenging":[110],"involves":[112],"multiple":[113],"phases,":[114],"including":[115],"discovery":[116],"\"druggable\"":[118],"targets,":[119,226],"preclinical":[120],"studies,":[121],"human":[122],"clinical":[123],"trials,":[124],"adoption":[127],"implementation":[129],"new":[132],"medication":[133,176],"mainstream":[135],"medicine.":[136],"successful":[138],"program":[141],"requires":[142],"clearly":[143],"established":[144],"goals":[145,187],"each":[147,189,206],"phase":[148,190],"ensure":[150],"candidate":[153],"compound":[154],"trapped":[157],"one":[159],"particular":[160],"phase,":[161,207],"condition":[163],"known":[164],"\"the":[166],"valley":[167],"death.\"":[169],"In":[170,197],"article,":[172],"phases":[174],"described":[179],"they":[181],"apply":[182],"specific":[186],"identified":[192],"next":[195],"decade.":[196],"addition,":[198],"several":[199],"important":[200],"crosscutting":[201],"themes":[202],"outlined":[204],"all":[208],"which":[210],"essential":[212],"advancing":[214],"development.":[216],"These":[217],"include":[218],"identifying":[219],"validating":[221],"screening":[222],"models":[223],"druggable":[225],"making":[227],"precision":[230],"medicine,":[231],"establishing":[233],"partnerships":[234],"among":[235],"key":[236],"stakeholders.":[237],"Our":[238],"goal":[239],"writing":[241],"article":[243],"provide":[246],"guide":[248],"will":[253],"research":[257],"community":[258],"planning,":[260],"testing,":[261],"AUD.":[266]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2400828834","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
